Quinotolast sodium

Quinotolast sodium in the concentration range of 1-100 μg/mL inhibits histamine, LTC4 and PGD2 release in a concentration-dependent manner.

Product Specifications

CAS Number

[101193-62-8]

Product Name Alternative

FR71021

UNSPSC

12352005

Target

Histamine Receptor; Leukotriene Receptor; Prostaglandin Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Quinotolast_(sodium).html

Purity

98.38

Solubility

DMSO : 115 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(NC1=NN=NN1)C2=CC(OC3=CC=CC=C3)=C4N(C2=O)C=CC=C4.[Na]

Molecular Formula

C17H12N6NaO3

Molecular Weight

371.31

References & Citations

[1]Okayama Y, et al. Inhibition of histamine and eicosanoid release from dispersed human lung cells in vitro byquinotolast. Jpn J Pharmacol. 1995 Dec;69 (4) :375-80.|[2]Kobayashi K, et al. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Jpn J Pharmacol. 1993 Sep;63 (1) :73-81.